Nautilus Biotechnology to Participate in Upcoming September Investor Conferences
Nautilus Biotechnology (NASDAQ: NAUT), a pioneer in single-molecule protein analysis platforms, has announced its participation in two upcoming investor conferences in September 2025.
The company will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York on September 8th at 1:50 PM ET. Additionally, management will present at the Q3 Investor Summit Group Virtual Conference on September 16th at 1:00 PM ET, with one-on-one meetings scheduled for September 17th.
Webcasts of both presentations will be accessible through the Investors section of Nautilus's website.
Nautilus Biotechnology (NASDAQ: NAUT), pioniere nelle piattaforme di analisi delle proteine a singola molecola, ha annunciato la sua partecipazione a due conferenze per investitori in programma a settembre 2025.
La società parteciperà a una fireside chat al Morgan Stanley 23rd Annual Global Healthcare Conference a New York l'8 settembre alle 13:50 ET. Inoltre, il management terrà una presentazione al Q3 Investor Summit Group Virtual Conference il 16 settembre alle 13:00 ET, con incontri one-to-one previsti per il 17 settembre.
I webcast di entrambe le presentazioni saranno disponibili nella sezione Investors del sito web di Nautilus.
Nautilus Biotechnology (NASDAQ: NAUT), pionera en plataformas de análisis de proteínas a nivel de molécula única, ha anunciado su participación en dos próximas conferencias para inversores en septiembre de 2025.
La compañía participará en una charla tipo fireside en el Morgan Stanley 23rd Annual Global Healthcare Conference en Nueva York el 8 de septiembre a la 1:50 PM ET. Además, la dirección realizará una presentación en el Q3 Investor Summit Group Virtual Conference el 16 de septiembre a la 1:00 PM ET, con reuniones individuales programadas para el 17 de septiembre.
Las retransmisiones en directo de ambas presentaciones estarán disponibles en la sección Investors del sitio web de Nautilus.
Nautilus Biotechnology (NASDAQ: NAUT), 단일 분자 단백질 분석 플랫폼의 선구자인 회사가 2025년 9월에 열리는 두 건의 투자자 컨퍼런스에 참가한다고 발표했습니다.
회사는 9월 8일 오후 1시 50분(동부시간)에 뉴욕에서 열리는 Morgan Stanley 23rd Annual Global Healthcare Conference의 파이어사이드 채팅에 참여합니다. 또한 경영진은 9월 16일 오후 1시(동부시간)에 열리는 Q3 Investor Summit Group Virtual Conference에서 발표를 진행하며, 9월 17일에는 일대일 미팅이 예정되어 있습니다.
두 발표 모두의 웹캐스트는 Nautilus 웹사이트의 Investors 섹션을 통해 시청할 수 있습니다.
Nautilus Biotechnology (NASDAQ: NAUT), pionnier des plateformes d'analyse des protéines au niveau de la molécule unique, a annoncé sa participation à deux conférences pour investisseurs prévues en septembre 2025.
La société prendra part à une conversation informelle (fireside chat) lors du Morgan Stanley 23rd Annual Global Healthcare Conference à New York le 8 septembre à 13h50 ET. De plus, la direction présentera au Q3 Investor Summit Group Virtual Conference le 16 septembre à 13h00 ET, avec des réunions individuelles prévues le 17 septembre.
Les webcasts des deux présentations seront accessibles depuis la rubrique Investors du site web de Nautilus.
Nautilus Biotechnology (NASDAQ: NAUT), ein Pionier für Einzelmolekül-Proteinanalytik-Plattformen, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen im September 2025 angekündigt.
Das Unternehmen wird an einem Fireside-Chat auf der Morgan Stanley 23rd Annual Global Healthcare Conference in New York am 8. September um 13:50 Uhr ET teilnehmen. Zudem wird das Management am Q3 Investor Summit Group Virtual Conference am 16. September um 13:00 Uhr ET präsentieren, mit Einzelgesprächen am 17. September.
Webcasts beider Präsentationen sind über den Investors-Bereich der Nautilus-Website zugänglich.
- None.
- None.
SEATTLE, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the following investor conferences.
- Morgan Stanley 23rd Annual Global Healthcare Conference in New York, NY
Management is scheduled to participate in a fireside chat on Monday, September 8h at 10:50 a.m. Pacific Time / 1:50 p.m. Eastern Time.
- Q3 Investor Summit Group Virtual Conference
Management is scheduled to present on Tuesday, September 16th at 10:00 a.m. Pacific Time / 1:00 p.m. Eastern Time and will host 1x1 meetings on Wednesday, September 17th.
Interested parties may access live and archived webcasts of the presentations on the “Investors” section of the company website at: www.nautilus.bio.
About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.
Media Contact
press@nautilus.bio
Investor Contact
investorrelations@nautilus.bio
FAQ
When is Nautilus Biotechnology (NAUT) presenting at the Morgan Stanley Healthcare Conference 2025?
What conferences will Nautilus Biotechnology (NAUT) attend in September 2025?
How can investors access Nautilus Biotechnology's (NAUT) conference presentations?
When will Nautilus (NAUT) host one-on-one meetings at the Q3 Investor Summit?
